During the past decade, Clinical Research of Charlotte conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 31 clinical trials were completed, i.e. on average, 64.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 26 clinical trials were completed. i.e. 185.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research of Charlotte" #1 sponsor was "Shire" with 9 trials, followed by "Aimmune Therapeutics, Inc." with 6 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 6 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 5 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 5 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research of Charlotte" #1 collaborator was "Takeda Development Center Americas, Inc." with 4 trials as a collaborator, "H. Lundbeck A/S" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator and "Clinilabs, Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research of Charlotte" are "Cystic Fibrosis" (8 trials), "Alzheimer's Disease" (6 trials), "Depressive Disorder, Major" (6 trials), "HIV Infections" (6 trials) and "Peanut Allergy" (6 trials). Many other conditions were trialed in "Clinical Research of Charlotte" in a lesser frequency.

Most popular intervention types in "Clinical Research of Charlotte" are "Drug" (60 trials), "Biological" (8 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "IVA" (6 trials), "Rapastinel" (5 trials), "AC2993" (4 trials) and "AR101" (4 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research of Charlotte" are 69 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Research of Charlotte". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 49 completed trials in Clinical Research of Charlotte, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research of Charlotte, 4 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".